Best Cannabis HealthTech Companies in Israel
The 40 best Cannabis HealthTech companies in Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Syqe.
- ResearchAndMarkets.com
Ranked: Best Cannabis HealthTech companies in Israel
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Syqe Developer of an inhaler for precise dosing of medical cannabis | $83M | 92 mo ago | Acquired | Perry Davidson Co-Founder | 2011 | Cart FunctionalityWooCommerceWordPress+31 | — | — |
| 2 | Panaxia Provider of medical cannabis products | $17M | 77 mo ago | Public | Dadi Segal Founder & CEO | 2009 | WordPressMySQLPHP+22 | 2 patents Pharmaceutical benzyl‑alcohol formulations for premature ejaculation treatment | — |
| 3 | Therapix Biosciences Developing cannabinoid-based therapies for CNS disorders | $13M | 66 mo ago | Acquired | Amitay Weiss CEO | 2014 | — | 36 patents Therapeutic formulations combining cannabinoids or opioids with N‑acylethanolamines and related biologics | — |
| 4 | IMCannabis Developer of medical cannabis products | $6M | 21 mo ago | Public | Oren Shuster CEO | 2008 | WordPressMySQLPHP+15 | — | — |
| 5 | OWC Pharmaceutical Research Developer of cannabis-based therapeutics for multiple ailments | $5M | 100 mo ago | Public | Zvi Riterband CEO | 2008 | — | — | — |
| 6 | Formulex Developer of cannabinoid drug products | $1M | 211 mo ago | Series A | Galia Krayz CEO | 2001 | — | — | — |
| 7 | Kanabo Developer of cannabis-derived products, vaporizers, and non-smoking consumption solutions | $1M | 77 mo ago | Acquired | David Sack Co-Founder | 2016 | WordPressMySQLPHP+19 | — | — |
| 8 | Cannabis Technology House Provider of smart devices for cannabis delivery system | $1M | 75 mo ago | Seed | Yuval Malka Co-Founder & CEO | 2019 | — | — | — |
Top 8 Cannabis HealthTech companies in Israel
#1
Public · Herzliya, Tel Aviv · founded 2008 · 153 employees$5.8Mraised▾
Developer of medical cannabis productss. It has developed strains & oils, and products for various diseases like oncology, PTSD, epilepsy, Crohn's & colitis, ALS, fibromyalgia, multiple sclerosis, Parkinson's, Tourette, chronic pain, eating disorder, and others.
- Nov 2024Post IPO$1.5M
- Jan 2023Post IPO$950.6K
- Oct 2022Post IPO$556.3K
- Aug 2022Post IPO$2.4M
#2
Acquired · Tel Aviv, Tel Aviv · founded 2011 · 108 employees$83Mraised▾
Developer of an inhaler for precise dosing of medical cannabis. The Inhalation system Air releases a measured amount of THC that reduces pain, control psychoactive side effects, and allows optimal daily functioning.
- Dec 2018Series A$50M
- Nov 2018Series A$3.4M
- Jan 2016Series A$20M
- Apr 2015Seed$2.2M
#3
Acquired · Givatayim, Tel Aviv · founded 2014$13Mraised▾
Therapix Biosciences is focused on developing drugs primarily for central nervous system (CNS) disorders. Using its IP portfolio of prescribed cannabinoid drugs and novel delivery systems, it is developing its pipeline. It currently has 2 development programs which include Brain Bright, a synthetic cannabinoid-based therapy for brain-related conditions, and Tourette Syndrome therapy based upon the entourage effect phenomenon among which the latter received an orphan drug designation.
- Mar 2021Post IPO$8.2M
- Jun 2020Post IPO$2.6M
- Apr 2019Post IPO$2.2M
#4
Public · Lod, Central District · founded 2009 · 167 employees$17Mraised▾
Panaxia is a provider of medical cannabis products. It has developed various products such as dried powder inhaler, cannabis gel and jellies, and many more. These cannabis products help in treating various diseases like smoking addiction, swallowing dysfunction, and others.
- Apr 2020Post IPO$17M
#5
Public · Petah Tikva, Central District · founded 2008$5Mraised▾
Developer of cannabis-based therapeutics for multiple ailments. The company is developing topical creams and sublingual disintegrating tablets for several medical conditions, like multiple myeloma, psoriasis, fibromyalgia, PTSD (post-traumatic stress disorder), and migraines.
- May 2018Post IPO$5M
#6
Acquired · Tel Aviv, Tel Aviv · founded 2016 · 19 employees$1.1Mraised▾
Developer of cannabis-derived products, vaporizers, and non-smoking consumption solutions. The company focuses on cannabis oil formulas and medical-grade vaporizers. It conducts research and development to create high-quality products. Clinical and validation activities, including safety and efficiency tests, are performed.
- Mar 2020Seed$1.1M
#7
Seed · Ness Ziona, Center District · founded 2019$1Mraised▾
Provider of smart devices for cannabis delivery system. It provides a natural flower-based delivery system with sensory experience.
- May 2020Seed$1M
#8
Series A · Rehovot, Central District · founded 2001$1.4Mraised▾
Formulex is a developer of cannabinoid drug products. The company is a developer of nano-technology based drug delivery and formulations. The products developed are Solumer, OMEXA and NASAX.
- Feb 2009Series A$1.4M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Cannabis HealthTech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.